HOME >> MEDICINE >> NEWS
Treating autism 'right the first time'

Autism therapy is bedeviled by unpredictable outcomes. Even with the best behavioral treatments, which are the only ones to have been scientifically demonstrated to work says Laura Schreibman, professor of psychology and director of the Autism Research Program at the University of California, San Diego some children improve dramatically, some only somewhat and others not at all.

Many families try one thing after another, losing precious months before hitting on the therapeutic method best suited for their autistic child. Given the importance of early intervention, Schreibman said, "we need to get it right the first time."

A new study coauthored by Schreibman and recent doctoral graduate Michelle Sherer successfully matches autistic children with an appropriate therapy. Published in the June issue of the American Psychological Association's Journal of Consulting and Clinical Psychology, the study is the first to develop and test a predictive profile of children likely to respond to a particular treatment, in this case Pivotal Response Training.

PRT is a child-directed behavioral intervention developed by Schreibman and UC Santa Barbara colleague Robert L. Koegel. Focused on improving a child's motivation and responsiveness, PRT targets language skills, play skills and social behaviors that can be generalized to a natural, non-lab setting.

The researchers began by examining data from 28 children who had participated in previous investigations of PRT. Characteristics of the poorest and most exceptional responders were used to develop the predictive profile. Children expected to do well with PRT were those who showed a moderate to high interest in toys, were tolerant of another person in close proximity, and, relative to those with poor outcomes, had fewer non-verbal stimulatory behaviors (flapping or rocking, for example) and more verbal self-stimulatory behaviors (squeaking or other nonsensical sounds).

A prospective stu
'"/>

Contact: Inga Kiderra
ikiderra@ucsd.edu
858-822-0661
University of California - San Diego
1-Jun-2005


Page: 1 2 3

Related medicine news :

1. Treating HIV in war zones -- Public health emergencies need rapid advice from WHO
2. Treating prostate cancer in elderly men associated with longer survival, compared to non-treatment
3. AASM position statement: Treating insomnia with over-the-counter sleep aids, herbal supplements
4. Treating medically unexplained symptoms
5. Treating obesity may improve the efficacy of therapy for hepatitis C
6. Treating populations infected with HIV and latent TB could speed the emergence of drug-resistant TB
7. Treating glaucoma early lowers economic burden
8. Treating gum disease may reduce the risk of cardiovascular disease
9. Treating multiple brain tumors with radiosurgery results in improved survival
10. Treating individuals with substance-abuse disorders who have attempted suicide
11. Treating mental health in general practice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Treating autism right the first time

(Date:6/19/2013)... After investing efforts for months in ... formally announced the launch of database integration for the ... latest entry in the list of extraordinary vehicles lined ... redesigned 2012 Nissan NV is all ready to get ... , Provided with two high power capable engines, the ...
(Date:6/19/2013)... Audibel Hearing Center is pleased ... patients, the A2 with Multiflex Tinnitus Technology. Tinnitus ... in the ears. Although bothersome, tinnitus usually isn’t ... , Using their patent-pending Multiflex Tinnitus Technology, the ... sound stimulus that resonates through the patient’s ear. ...
(Date:6/19/2013)... June 19, 2013 According to Vanessa ... abusers called “psychonauts” are creating new designer drugs featuring ... research of published documents and patented formulas. She reported ... & Now on June 4. , “Some of ... They’re never tested on humans. Maybe some of them ...
(Date:6/19/2013)... The Report "Data Center Security Market ... DLP, UTM, IAM, SIEM, DR, ILM); Physical Security ... Advancements, Forecasts & Analysis (2013-2018)", defines and segments ... sub-segments with in-depth analysis and forecasting of revenues. ... market with insights into trends, opportunities, and challenges. ...
(Date:6/19/2013)... Tewkesbury, UK (PRWEB) June 19, 2013 ... solutions, is sponsoring today's event, at which it will ... issues, as well as giving further insight into its ... gathering for IT & business professionals specialising in IDM ... wide range of markets including the public sector, banking, ...
Breaking Medicine News(10 mins):Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4
(Date:6/18/2013)... Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader in ... corporate update in conjunction with its 2013 Annual Meeting of ... p.m. Pacific Time in Carlsbad, CA. ... 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders (only ... p.m. – 3:15 p.m. Corporate Presentation – Stanley T. ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
Cached News: